Build your foundation. Avoid costly mistakes. Get grounded in the essentials of export controls and compliance. This session covers the key regulations, common pitfalls (including dual-use items), and why compliance matters – because mistakes can carry serious consequences. Perfect for…
BIS: Portland Company Faces Three-Year Export Denial Order for Persistent EAR Violations
BIS: Portland Company Faces Three-Year Export Denial Order for Persistent EAR Violations
June 20, 2024/
USGoBuy, a Portland, OR company, has had a three-year denial order issued. This prohibits them for participating in all EAR-subject exports from the US. This is because USGoBuy, a package forwarding company, has had continued violations of the EAR and failed to address their compliance failures. The package forwarding business model is to allow non-US customers to buy things online from US retailers and have them shipped to the Oregon warehouse, then consolidating the packages and exporting them from the US.
Related Posts
NMFS: Upcoming Import Prohibitions and Industry Webinars
The National Marine Fisheries Service (NMFS) announces that, effective January 1, 2026, imports of specific fish and fish products from countries whose fisheries have not received comparability findings under the Marine Mammal Protection Act (MMPA) will be restricted from entering the United States. To help industry prepare for these changes, NMFS will host two informational…
CBP: Settlement Reached in Aluminum Extrusions Duty Evasion Case
Harman International Industries, parent company of Harman Kardon®, JBL®, and Mark Levinson®-has agreed to pay $11,809,628 to settle allegations that it evaded antidumping and countervailing duties (ADCVD) on aluminum-extrusion heatsinks imported from China. According to the allegations, the company failed for more than a decade to disclose or correct the violations and actively concealed the…
USTR: U.S. and U.K. Reach Agreement on Pharmaceuticals and Medical Technology
On December 1, 2025, the United States and United Kingdom announced a new agreement on pharmaceuticals, pharmaceutical ingredients, and medical technology. Under this arrangement, the U.S. would remove Section 232 tariffs on U.K.-sourced medical goods, pause any Section 301 investigations related to U.K. pharmaceutical pricing during President Trump’s term, and collaborate to expand U.K. patient…
FDA: Agency Deploys Agentic AI Capabilities for Staff Use
The U.S. Food and Drug Administration announced the rollout of agency-wide agentic AI tools designed to support employees with complex, multi-step tasks. These systems build on the FDA’s earlier deployment of its LLM-based tool, Elsa-currently used voluntarily by a majority of staff-and introduce more advanced features for workflow automation, planning, and reasoning. Participation remains optional,…